AN2 THERAPEUTICS, INC
MENLO PARK, CALIFORNIA 940253069
$13.54M
Total Contract Value
11 awards
First Award
Sep 20, 2022
Last Award
Nov 26, 2025
Business Size
small
CAGE Code
822Z2
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $9.24M | 10 |
Contract Awards
4 awards found
75N93022C00059
Department of Health and Human Services
$457K
Apr 28, 2025
DEVELOPMENT OF EPETRABOROLE AS A NOVEL THERAPEUTIC FOR MELIOIDOSIS AND ADDITIONAL ANTIMICROBIAL RESISTANT (AMR) BACTERIAL BIOTHREAT PATHOGENS.
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2025
75N93022C00059
Department of Health and Human Services
$3.82M
May 14, 2024
DEVELOPMENT OF EPETRABOROLE AS A NOVEL THERAPEUTIC FOR MELIOIDOSIS AND ADDITIONAL ANTIMICROBIAL RESISTANT (AMR) BACTERIAL BIOTHREAT PATHOGENS.
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75N93022C00059
Department of Health and Human Services
$651K
Jul 11, 2023
DEVELOPMENT OF EPETRABOROLE AS A NOVEL THERAPEUTIC FOR MELIOIDOSIS AND ADDITIONAL ANTIMICROBIAL RESISTANT (AMR) BACTERIAL BIOTHREAT PATHOGENS.
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75N93022C00059
Department of Health and Human Services
$4.31M
Sep 20, 2022
DEVELOPMENT OF EPETRABOROLE AS A NOVEL THERAPEUTIC FOR MELIOIDOSIS AND ADDITIONAL ANTIMICROBIAL RESISTANT (AMR) BACTERIAL BIOTHREAT PATHOGENS.
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2022
Business Details
- UEI
- DD4FE2GE4L78
- CAGE Code
- 822Z2
- Address
- 171 FOREST LN
MENLO PARK, CA 940253069 - Congressional District
- CA-16
- Phone
- 6508049077
Parent Company
AN2 THERAPEUTICS, INC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov